Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
May We Target Double-Membrane Vesicles and Oxysterol-Binding Protein to Combat Sars-Cov-2 Infection? Publisher Pubmed



Shahmohamadnejad S1 ; Nabavi SF2, 3 ; Habtemariam S4 ; Sarkar K5 ; Sil PC6 ; Dowran R7 ; Nabavi SM2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
  3. 3. Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran
  4. 4. Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Chatham-Maritime, Kent, United Kingdom
  5. 5. Department of Microbiology, St. Xavier's College, Kolkata, India
  6. 6. Department of Molecular Medicine, Bose Institute, Kolkata, India
  7. 7. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Cell Biology International Published:2020


Abstract

[No abstract available]
Other Related Docs
11. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
15. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
21. Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions, Eurasian Journal of Medicine and Oncology (2020)
23. A Review of Antibiotic Efficacy in Covid-19 Control, Journal of Immunology Research (2023)
29. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)
43. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)